Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer

Hannah M. Linden, Brenda F. Kurland, Lanell M. Peterson, Erin K. Schubert, Julie R. Gralow, Jennifer M. Specht, Georgiana K. Ellis, Thomas J. Lawton, Robert B. Livingston, Philip H. Petra, Jeanne M. Link, Kenneth A. Krohn, David A. Mankoff

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint Dive into the research topics of 'Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences